cisapride has been researched along with Esophageal Diseases in 5 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This hypothesis was tested in a small pilot study treating functional dysphagia with cisapride." | 3.68 | Oesophageal reflex responses: abnormalities of the enteric nervous system in patients with oesophageal symptoms. ( Bancewicz, J; Marples, M; O'Hanrahan, T; Thompson, D; Williams, D, 1992) |
| "The cisapride induced increase in oesophageal contractile force and propagation velocity seems to enhance the clearance of gastro-oesophageal reflux." | 2.67 | Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. ( Armstrong, D; Bettschen, HU; Blum, AL; Emde, C; Halter, F; Huber, T; Inauen, W; Merki, HS; Scheurer, U; Weber, B, 1993) |
| "Severe gastroesophageal reflux disease is usually a chronic problem with periods of relapse, but effective medical and surgical therapies are available." | 2.39 | Severe gastroesophageal reflux disease. Medical and surgical options for long-term care. ( Marshall, JB, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindahl, H | 1 |
| Rintala, R | 1 |
| Marshall, JB | 1 |
| Inauen, W | 1 |
| Emde, C | 1 |
| Weber, B | 1 |
| Armstrong, D | 1 |
| Bettschen, HU | 1 |
| Huber, T | 1 |
| Scheurer, U | 1 |
| Blum, AL | 1 |
| Halter, F | 1 |
| Merki, HS | 1 |
| Lee, P | 1 |
| Rudolph, C | 1 |
| O'Hanrahan, T | 1 |
| Bancewicz, J | 1 |
| Thompson, D | 1 |
| Marples, M | 1 |
| Williams, D | 1 |
2 reviews available for cisapride and Esophageal Diseases
| Article | Year |
|---|---|
Severe gastroesophageal reflux disease. Medical and surgical options for long-term care.
Topics: Antacids; Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophageal Diseases; Esophagogast | 1995 |
Gastroesophageal reflux in infants and children.
Topics: Anti-Ulcer Agents; Child; Child, Preschool; Cisapride; Esophageal Diseases; Fundoplication; Gastroes | 2001 |
1 trial available for cisapride and Esophageal Diseases
| Article | Year |
|---|---|
Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Topics: Adult; Aged; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Drug Therapy, Combination; Esophagea | 1993 |
2 other studies available for cisapride and Esophageal Diseases
| Article | Year |
|---|---|
Long-term complications in cases of isolated esophageal atresia treated with esophageal anastomosis.
Topics: Anastomosis, Surgical; Anti-Ulcer Agents; Cisapride; Constriction, Pathologic; Endoscopy, Digestive | 1995 |
Oesophageal reflex responses: abnormalities of the enteric nervous system in patients with oesophageal symptoms.
Topics: Adult; Aged; Catheterization; Cisapride; Deglutition Disorders; Esophageal Diseases; Esophagus; Fema | 1992 |